Tech Company Financing Transactions
Trailhead Biosystems Funding Round
MAK Capital and private investors joined a $20 million funding round for Trailhead Biosystems. The financing was recorded on 5/6/2025.
Transaction Overview
Company Name
Announced On
5/6/2025
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
MAK Capital (Lead Investor)
Proceeds Purpose
The funding will enhance Trailhead's rapidly expanding portfolio of iPSC-derived cells for research applications, advancing preclinical drug discovery and disease modeling.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
10000 Cedar Ave.
Cleveland, OH 44106
USA
Cleveland, OH 44106
USA
Phone
Website
Email Address
Not Recorded
Overview
Trailhead Biosystems is pioneering the development of cell-based therapeutics using machine learning and bioinformatics. Trailhead's High Dimensional Design of Experiments (HD-DoE) platform merges developmental biology and cell therapeutics with advanced robotics, computerized experimental design, and analysis to perform process-specific parameter optimization in the development of cell therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Magnus Persson
Chief Executive Officer
Jan Jensen
Chief Operating Officer
Div Trivedi
Browse more venture capital transactions:
Prev: 5/6/2025: Onebeat venture capital transaction
Next: 5/6/2025: DecisionRules venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs